Clinical Trials

Clinical trials are an important factor to consider when faced with the inevitability of cancer treatment. These studies involve experimental treatments in various stages of testing and development that may or may not provide a cancer patient with positive treatment results.

It is important for cancer patients to discuss the possibility of participating in clinical trials with their doctors. Trials often have very specific eligibility requirements, so it is important to know all the details regarding a specific trial before a patient's eligibility can be determined.

Our clinical trial listings are obtained from the trials listed through the National Institute of Health. While we strive to keep this listing up to date as much as possible, trials open and close all the time. Consequently, you should not assume that the trials listed on this site represent all that may be available at the current time. In addition to the trials listed here, other clinical trial information can be obtained from the National Cancer Institute, the American Cancer Society, and the National Institute of Health.

Our clinical trial listings are grouped according to the phase of the trial. The phases can be intepreted according to the following segmentation:

In Phase I trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase II trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase III trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

In Phase IV trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

Our trial listings indicate what stage the trial is in, whether it is currently recruiting patients, and whether it is applicable to non-small cell or small cell lung cancer. For example, a trial listing preceeded by:

would indicate that the trial is Phase I, accepting patients, and is applicable to both non-small cell, and small cell lung cancer.

The following listing:

would indicate that the trial is Phase III, not currently recruiting patients, and applicable to non-small cell lung cancer only.

About Us Step for Survival